Does the media prefer MMSI or OFIX?

In the previous week, Orthofix Medical had 1 more articles in the media than Merit Medical Systems. MarketBeat recorded 4 mentions for Orthofix Medical and 3 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.09 beat Orthofix Medical's score of -0.15 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Orthofix Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to ATRC or OFIX?

In the previous week, Orthofix Medical had 3 more articles in the media than AtriCure. MarketBeat recorded 4 mentions for Orthofix Medical and 1 mentions for AtriCure. AtriCure's average media sentiment score of 1.59 beat Orthofix Medical's score of -0.15 indicating that AtriCure is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Orthofix Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer IART or OFIX?

In the previous week, Integra LifeSciences and Integra LifeSciences both had 4 articles in the media. Integra LifeSciences' average media sentiment score of 0.34 beat Orthofix Medical's score of -0.15 indicating that Integra LifeSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Orthofix Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, OFIX or ATEC?

Orthofix Medical has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Orthofix Medical $822.31M 0.51 -$92.19M -$1.51 N/A Alphatec $787.08M 1.56 -$143.36M -$0.82 N/A

Is OFIX or ATEC more profitable?

Orthofix Medical has a net margin of -7.27% compared to Alphatec's net margin of -15.93%. Orthofix Medical's return on equity of -13.44% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets Orthofix Medical -7.27% -13.44% -7.05% Alphatec -15.93% -1,183.84% -15.83%

Does the media prefer OFIX or ATEC?

In the previous week, Orthofix Medical had 1 more articles in the media than Alphatec. MarketBeat recorded 4 mentions for Orthofix Medical and 3 mentions for Alphatec. Alphatec's average media sentiment score of 0.70 beat Orthofix Medical's score of -0.15 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orthofix Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Alphatec 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Orthofix Medical (OFIX) Competitors

$10.29 -0.05 (-0.48%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$10.28 -0.01 (-0.11%)

As of 06/5/2026 07:55 PM Eastern

Compare

OFIX vs. MMSI, ATRC, IART, ATEC, and ANGO

Should you buy Orthofix Medical stock or one of its competitors? MarketBeat compares Orthofix Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Orthofix Medical include Merit Medical Systems (MMSI), AtriCure (ATRC), Integra LifeSciences (IART), Alphatec (ATEC), and AngioDynamics (ANGO). These companies are all part of the "medical" sector.

How does Orthofix Medical compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and Orthofix Medical (NASDAQ:OFIX) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

In the previous week, Orthofix Medical had 1 more articles in the media than Merit Medical Systems. MarketBeat recorded 4 mentions for Orthofix Medical and 3 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.09 beat Orthofix Medical's score of -0.15 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Orthofix Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Merit Medical Systems currently has a consensus price target of $92.80, indicating a potential upside of 43.92%. Orthofix Medical has a consensus price target of $15.50, indicating a potential upside of 50.63%. Given Orthofix Medical's higher probable upside, analysts clearly believe Orthofix Medical is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Merit Medical Systems has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.71, indicating that its stock price is 29% less volatile than the broader market.

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by company insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Merit Medical Systems has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	2.54	$128.49M	$2.31	27.91
Orthofix Medical	$822.31M	0.51	-$92.19M	-$1.51	N/A

Merit Medical Systems has a net margin of 9.03% compared to Orthofix Medical's net margin of -7.27%. Merit Medical Systems' return on equity of 13.54% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
Orthofix Medical	-7.27%	-13.44%	-7.05%

Summary

Merit Medical Systems beats Orthofix Medical on 12 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to AtriCure?

AtriCure (NASDAQ:ATRC) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends.

In the previous week, Orthofix Medical had 3 more articles in the media than AtriCure. MarketBeat recorded 4 mentions for Orthofix Medical and 1 mentions for AtriCure. AtriCure's average media sentiment score of 1.59 beat Orthofix Medical's score of -0.15 indicating that AtriCure is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Orthofix Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

AtriCure has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market.

AtriCure has higher earnings, but lower revenue than Orthofix Medical. AtriCure is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	2.57	-$11.45M	-$0.10	N/A
Orthofix Medical	$822.31M	0.51	-$92.19M	-$1.51	N/A

AtriCure has a net margin of -0.83% compared to Orthofix Medical's net margin of -7.27%. AtriCure's return on equity of 0.29% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-0.83%	0.29%	0.22%
Orthofix Medical	-7.27%	-13.44%	-7.05%

AtriCure currently has a consensus price target of $48.71, indicating a potential upside of 79.76%. Orthofix Medical has a consensus price target of $15.50, indicating a potential upside of 50.63%. Given AtriCure's stronger consensus rating and higher possible upside, equities research analysts plainly believe AtriCure is more favorable than Orthofix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.82
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

99.1% of AtriCure shares are held by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are held by institutional investors. 4.0% of AtriCure shares are held by insiders. Comparatively, 2.7% of Orthofix Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

AtriCure beats Orthofix Medical on 14 of the 17 factors compared between the two stocks.

How does Orthofix Medical compare to Integra LifeSciences?

Integra LifeSciences (NASDAQ:IART) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Orthofix Medical has lower revenue, but higher earnings than Integra LifeSciences. Orthofix Medical is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.81	-$516.47M	-$6.46	N/A
Orthofix Medical	$822.31M	0.51	-$92.19M	-$1.51	N/A

Integra LifeSciences has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market.

Orthofix Medical has a net margin of -7.27% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-30.15%	17.42%	5.00%
Orthofix Medical	-7.27%	-13.44%	-7.05%

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Integra LifeSciences and Integra LifeSciences both had 4 articles in the media. Integra LifeSciences' average media sentiment score of 0.34 beat Orthofix Medical's score of -0.15 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Orthofix Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integra LifeSciences currently has a consensus price target of $14.00, suggesting a potential downside of 17.60%. Orthofix Medical has a consensus price target of $15.50, suggesting a potential upside of 50.63%. Given Orthofix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Orthofix Medical is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Integra LifeSciences beats Orthofix Medical on 8 of the 15 factors compared between the two stocks.

How does Orthofix Medical compare to Alphatec?

Orthofix Medical (NASDAQ:OFIX) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

Orthofix Medical has a beta of 0.71, suggesting that its share price is 29% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

Orthofix Medical has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$822.31M	0.51	-$92.19M	-$1.51	N/A
Alphatec	$787.08M	1.56	-$143.36M	-$0.82	N/A

Orthofix Medical has a net margin of -7.27% compared to Alphatec's net margin of -15.93%. Orthofix Medical's return on equity of -13.44% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-7.27%	-13.44%	-7.05%
Alphatec	-15.93%	-1,183.84%	-15.83%

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 66.3% of Alphatec shares are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by company insiders. Comparatively, 13.5% of Alphatec shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Orthofix Medical presently has a consensus price target of $15.50, suggesting a potential upside of 50.63%. Alphatec has a consensus price target of $18.58, suggesting a potential upside of 132.29%. Given Alphatec's stronger consensus rating and higher possible upside, analysts plainly believe Alphatec is more favorable than Orthofix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, Orthofix Medical had 1 more articles in the media than Alphatec. MarketBeat recorded 4 mentions for Orthofix Medical and 3 mentions for Alphatec. Alphatec's average media sentiment score of 0.70 beat Orthofix Medical's score of -0.15 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Orthofix Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alphatec	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Orthofix Medical and Alphatec tied by winning 8 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to AngioDynamics?

Orthofix Medical (NASDAQ:OFIX) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations.

AngioDynamics has lower revenue, but higher earnings than Orthofix Medical. AngioDynamics is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$822.31M	0.51	-$92.19M	-$1.51	N/A
AngioDynamics	$292.50M	1.69	-$33.99M	-$0.75	N/A

Orthofix Medical has a beta of 0.71, suggesting that its share price is 29% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market.

Orthofix Medical currently has a consensus target price of $15.50, suggesting a potential upside of 50.63%. AngioDynamics has a consensus target price of $18.67, suggesting a potential upside of 56.34%. Given AngioDynamics' stronger consensus rating and higher probable upside, analysts clearly believe AngioDynamics is more favorable than Orthofix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Orthofix Medical has a net margin of -7.27% compared to AngioDynamics' net margin of -10.01%. AngioDynamics' return on equity of -4.66% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-7.27%	-13.44%	-7.05%
AngioDynamics	-10.01%	-4.66%	-3.08%

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by insiders. Comparatively, 6.0% of AngioDynamics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Orthofix Medical had 4 more articles in the media than AngioDynamics. MarketBeat recorded 4 mentions for Orthofix Medical and 0 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 0.00 beat Orthofix Medical's score of -0.15 indicating that AngioDynamics is being referred to more favorably in the news media.

Company	Overall Sentiment
Orthofix Medical	Neutral
AngioDynamics	Neutral

Summary

AngioDynamics beats Orthofix Medical on 10 of the 16 factors compared between the two stocks.

Get Orthofix Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OFIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OFIX vs. The Competition

Export

Metric	Orthofix Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$417.96M	$7.32B	$6.48B	$12.46B
Dividend Yield	N/A	1.20%	2.67%	5.34%
P/E Ratio	-6.81	45.87	23.69	23.64
Price / Sales	0.51	74.35	520.34	113.83
Price / Cash	N/A	24.88	42.35	57.17
Price / Book	0.91	7.04	9.73	6.37
Net Income	-$92.19M	$159.22M	$3.56B	$337.36M
7 Day Performance	11.00%	-2.43%	-2.91%	-2.38%
1 Month Performance	-15.59%	3.34%	-0.84%	-0.57%
1 Year Performance	-6.20%	-0.35%	22.24%	25.53%

Orthofix Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OFIX Orthofix Medical	4.3843 of 5 stars	$10.29 -0.5%	$15.50 +50.6%	-3.9%	$417.96M	$822.31M	N/A	1,605
MMSI Merit Medical Systems	4.7055 of 5 stars	$60.82 -2.0%	$92.80 +52.6%	-32.3%	$3.76B	$1.54B	26.70	7,500
ATRC AtriCure	3.7293 of 5 stars	$25.86 -2.3%	$48.71 +88.4%	-22.3%	$1.40B	$534.53M	N/A	1,300	Gap Up
IART Integra LifeSciences	1.0612 of 5 stars	$15.68 +0.1%	$14.00 -10.7%	+27.8%	$1.22B	$1.64B	N/A	4,427	News Coverage
ATEC Alphatec	3.7356 of 5 stars	$7.47 -0.2%	$18.58 +148.9%	-35.7%	$1.19B	$764.16M	N/A	700	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OFIX) was last updated on 6/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Orthofix Medical (OFIX) Competitors

OFIX vs. MMSI, ATRC, IART, ATEC, and ANGO

How does Orthofix Medical compare to Merit Medical Systems?

Summary

How does Orthofix Medical compare to AtriCure?

Summary

How does Orthofix Medical compare to Integra LifeSciences?

Summary

How does Orthofix Medical compare to Alphatec?

Summary

How does Orthofix Medical compare to AngioDynamics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OFIX vs. The Competition

Orthofix Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Orthofix Medical (OFIX) Competitors

OFIX vs. MMSI, ATRC, IART, ATEC, and ANGO

How does Orthofix Medical compare to Merit Medical Systems?

Does the media prefer MMSI or OFIX?

Do analysts prefer MMSI or OFIX?

Which has more risk and volatility, MMSI or OFIX?

Do institutionals & insiders hold more shares of MMSI or OFIX?

Which has higher valuation & earnings, MMSI or OFIX?

Is MMSI or OFIX more profitable?

Summary

How does Orthofix Medical compare to AtriCure?

Does the media refer more to ATRC or OFIX?

Which has more risk & volatility, ATRC or OFIX?

Which has higher earnings & valuation, ATRC or OFIX?

Is ATRC or OFIX more profitable?

Do analysts prefer ATRC or OFIX?

Do institutionals and insiders believe in ATRC or OFIX?

Summary

How does Orthofix Medical compare to Integra LifeSciences?

Which has stronger earnings & valuation, IART or OFIX?

Which has more volatility and risk, IART or OFIX?

Is IART or OFIX more profitable?

Do institutionals & insiders have more ownership in IART or OFIX?

Does the media prefer IART or OFIX?

Do analysts recommend IART or OFIX?

Summary

How does Orthofix Medical compare to Alphatec?

Which has more volatility & risk, OFIX or ATEC?

Which has better valuation & earnings, OFIX or ATEC?

Is OFIX or ATEC more profitable?

Do insiders & institutionals have more ownership in OFIX or ATEC?

Do analysts recommend OFIX or ATEC?

Does the media prefer OFIX or ATEC?

Summary

How does Orthofix Medical compare to AngioDynamics?

Which has higher earnings and valuation, OFIX or ANGO?

Which has more risk and volatility, OFIX or ANGO?

Do analysts recommend OFIX or ANGO?

Is OFIX or ANGO more profitable?

Do insiders and institutionals have more ownership in OFIX or ANGO?

Does the media prefer OFIX or ANGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OFIX vs. The Competition

Orthofix Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools